The decreased ability to activate PI3K/AKT pathway could derive from several pathological facets related to IR and T2DM, including the mutation of this pathway itself, dysregulation of some regulator proteins or other signaling pathways, lipid accumulation or alteration, reduced circulating adiponectin, and enhanced inflammation state. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.